
In this episode, Dr. Ambreesh Chawla offers a preview of his upcoming ACR Convergence session exploring the complex relationship between medications and rheumatologic disease. He discusses unusual rheumatologic complications associated with commonly prescribed medications, including dupilumab-associated enthesitis, proton pump inhibitors (PPIs), and DPP-4 inhibitors. Through interactive cases and clinical scenarios, the session challenges clinicians to ask an important question: Is it disease, or is it drug? Dr. Chawla also shares insights into his journey from biomedical engineering to rheumatology, his passion for medical education, and how he makes the most of the ACR Convergence experience.
Więcej odcinków z kanału "ACR Journals On Air"



Nie przegap odcinka z kanału “ACR Journals On Air”! Subskrybuj bezpłatnie w aplikacji GetPodcast.








